COST Action B22 on
"Drug development for parasitic diseases"
2003-2007
COST B22 Working Group 1 and
Working Group 2 meeting on June 25th, 2004
On that day the WG1 on "Drug target identification" and WG2 on "Drug target characterization and drug development" of COST Action B22, "Drug Development for Parasitic Diseases" will meet in Brussels in the ICP, "Michel de Visscher" lecture hall from 9 -17 h. In this expert meeting the various experts of COST B22 wil present their research and discuss their future plans for the COST action. The scientific part will be open to everybody interested in the subject matter. The idea is that every member of WG1 and /or WG2 who will participate, presents his or her research as far as this relates to the COST B22 activities. Presentations should not be longer than 30 min, discussion included.
Local organiser: Fred Opperdoes
Venue: ICP, "Michel de Visscher" lecture hall, Avenue Hippocrate 74, 1200 Brussels (tel. 02/7647439)
Programme and participants
Salam Al-Karadaghi
(University of Lund)
Structural aspects of polyamine synthesis enzymes as drug
targets
Theodora Calogeropoulou
(National Hellenic Research Foundation, Athens)
Antileishmanial ring-substituted ether phospholipids
Graham Coombs (University
of Glasgow)
Drug target identification, validation and characterisation at the
University of Glasgow.
Michael Duchene (University
of Vienna)
Targeting Entamoeba histolytica with methods of genomics and
proteomics
Maria Durisova (Slovak
Academy of Sciences)
New advanced modeling methods in development of new drugs and drug
formulations.
Dolores Gonzales-Pacanovska
(Instituto de Parasitologia y Biomedicina
'Lopez-Neyra',Granada)
Enzymes involved in sterol and pyrimidine metabolism as drug
targets in parasitic protozoa
Luise Krauth-Siegel
(University of Heidelberg)
Enzymes of the trypanothione redox metabolism of trypanosomes as
drug target molecules
Fred Opperdoes (ICP,
Brussels)
Comparison of L. major , T. brucei and T. cruzi
metabolism from genomic information
Louis Tielens (University
of Utrecht)
The mitochondrial metabolism in trypanosomatids
Ivor Tittawella.
(University of Umea)
Mitochondrial activity in bloodstream African trypanosomes: A
potential target for drugs?
Henri Vial (CNRS University
Montpellier II)
Peculiarities of the phospholipid metabolism in the
malaria-causing parasite Plasmodium and pharmacological
implications
Rolf Walter (Bernhard Nocht
Institute for Tropical Medicine, Hamburg)
Polyamine metabolism of Plasmodium falciparum as a drug
target.
Dan Zilberstein (Technion -
Israel Institute of Technology, Haifa)
Investigating Sb(V) mode of action in Leishmania using
host-free system
Joint discussion of members of working groups 1 and 2